US Pentagon’s testosterone program exposes gender bias and health inequities in military care
Original framing: “Judge orders Hegseth to explain US military’s new testosterone policy” — The Guardian - World
Scientific literature indicates that testosterone supplementation in otherwise healthy men yields modest gains in muscle mass but carries risks such as cardiovascular events and mood disturbances. Moreover, gender‑affirming hormone therapy for transgender individuals has been shown to improve mental health outcomes and operational readiness when properly administered. The Pentagon’s selective application of hormone therapy therefore lacks a consistent evidence base and selectively cites data to justify a gendered policy.
The Pentagon’s testosterone initiative is less a neutral medical program than a manifestation of entrenched gender hierarchies, historical patterns of selective health interventions, and political signaling to a conservative base.
By ignoring Indigenous, trans, and cross‑cultural perspectives, the policy perpetuates inequities that undermine both individual wellbeing and collective readiness. Integrating independent oversight, parity in care, and robust outcomes research can transform the policy into a model of inclusive, evidence‑based military health. Such a shift would align the armed forces with broader societal movements toward gender justice while preserving operational effectiveness.